Aims: The aim of the study was to investigate the expression of alpha-B-crystallin and p53 in
INTRODUCTION
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide with a global annual incidence of 500,000. 1 HNSCC is a heterogeneous group of cancers, with a variable, but usually poor prognosis in patients. 1 Despite advances in treatment, the mortality rate of HNSCC has not changed markedly over the last few decades. 2 Besides the poor outcome, head and neck cancer has a great impact on the patient's quality of life, due to its anatomic location. The cancer treatment involves pain and disfigurement and it can affect speech, breathing and swallowing. 3 Clinicopathological criteria are important for the management and prediction of outcome of patients. However, within a group of patients sharing the same features, there is still significant variation in prognosis. Studies on the carcinogenesis in HNSCC can lead to understand its biological behaviour and to reveal the underlying mechanisms of cancer progression and therapy resistance. 4 The tumour suppressor gene p53, located on the short arm of chromosome 17, is known as 'the guardian of the genome'. 5 Its key function is the control of cell cycle. P53 has the ability to detect either physical or chemical DNA damage. In response, by acting as a transcription factor, it activates other genes necessary for cell cycle arrest; thereby allowing DNA-repair before duplication. If damage to DNA is too severe, the cell will undergo apoptosis. Mutation of the p53 gene is the most common mutation in human cancer; 40-50% of HNSCC carry a p53 mutation. 6 Inactivation of p53 will deregulate this control function in the cell cycle. Despite the presence of DNA damage, the cell will continue its replication instead of undergoing apoptosis. This contributes to genomic instability and makes the cell relatively resistant to chemo-and radiotherapy. 5, 7 The wild type p53 protein has a short halflife and cannot be detected by immunohistochemistry. The mutated p53 protein usually has a long half-life and therefore can be detected by immunohistochemistry.
Alpha-B-crystallin is a member of small heat-shock proteins and has a cytoprotective function. Under physiologic conditions, the level of small heat-shock proteins in tissues is low. 8 One exception is in the eye lens where alpha-B-crystallin accounts for 40 percent of the cytoplasmic proteins and plays a role in maintaining its transparency. 9 Alpha-B-crystallin is elevated under physiologic stress, neurodegenerative diseases and cancer, eg gliomas, renal carcinomas and breast carcinomas. 9 Alpha-B-crystallin acts as a molecular chaperone, by preventing aggregation of denatured proteins after exposure to stresses such as heat shock, radiation, oxidative stress and anticancer drugs. 10 Furthermore, it has a strong anti-apoptotic effect. Alpha-B-crystallin interacts with different apoptotic proteins at key regulatory points in the control of apoptosis. 8 It inhibits the proteolytic activation of caspase-3 11 and binds to pro-apoptotic Bcl-2 family members, Bax and Bcl-x s
10
, thereby preventing their translocation to the mitochondria. It has also been shown that alpha-B-crystallin protects cells from death induced by proteasome inhibition. 8 The role of alpha-B-crystallin in these apoptotic pathways can be an important mechanism in therapy resistance. Kamradt et al in 2005 reported alpha-B-crystallin is an inhibitor of TRAIL (tumour necrosis factor-related apoptosis-inducing ligand)-induced apoptosis, which is a promising anti-tumour reagent. 12 As both P53 and alpha-B-crystallin play roles in apoptotic pathways in tumourigenesis, the aim of this study is to evaluate these roles in Australian patients with head and neck squamous cell carcinomas. This is the largest series for the study of alpha-Bcrystalline in HNSCC.
MATERIAL AND METHODS

Patients and tumour tissues
Between September 1997 and December 2005, 208 patients were diagnosed with head and neck squamous cell carcinoma at the Gold Coast Hospital in Queensland, Australia. In this study, patients with cancers of lips and oesophagus were excluded from the study. The pathology of the other patients was reviewed by the authors (KB and AKYL) according to the World Health Organization of tumours. 13 After the review, paraffin blocks from these patients were chosen for immunohistochemical study. In the selection of the paraffin blocks, normal tissue and dysplastic mucosa was included, whenever possible, with the tumour.
One hundred and eighteen patients (31 women and 88 men) with a mean age of 62 were selected. Of these, 34.7% (n=41) of the SCC were located in the oral cavity, 27.1% 
Statistical analysis
Categorical data was analyzed with either the chi-square test or the Fisher's exact test, depending on the number of cases. Disease-free survival (time between diagnosis of primary tumour and recurrence) and overall survival (time between diagnosis of primary tumour and death) were calculated using the Kaplan-Meier method. The log rank test was used to compare the survival curves of different groups. A P-value (p < 0.05) was considered as statistically significant. Data analysis was performed using SPSS (Statistical Package for the Social Sciences for Windows, version 14.0, Chicago, IL, USA)
RESULTS
Pathological features
Thirty-five percent (n=41) of the cancers were classified as well differentiated, 56% (n=66) as moderately differentiated and 9% (n=11) Positive staining was also seen in some dysplastic lesions. The non-tumour tissue was negative for p53.
The relationship between p53 positivity and the clinicopathological parameters were shown in Table 1 . P53 immunoreactivity correlated with the differentiation of the tumour. It is more often noted in higher grade lesions. Also, grade two and grade three p53 positivity were seen more frequently in moderately and poorly differentiated squamous cell carcinomas (Chi-square test, p=0.034). The prevalence of p53 expression differed between the different sites. P53 positive staining was less frequently observed in tumours from the larynx (50%; n=14/28), in comparison with the oropharynx (66%; n=21/32), hypopharynx (65%; n=11/17) and the oral cavity (66%; n=27/41) although not statistically significant (p=0.182). There was no correlation found between p53 positivity with gender, age, TNM stage and the event of recurrence.
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Alpha-B-crystallin immunoreactivity
The alpha-B-crystallin positivity was seen as cytoplasmic staining. Alpha-Bcrystallin expression was seen in 28% (n=33) of the HNSCC, of which 19 cases classified as grade one, 10 cases as grade two and 4 cases as grade three. In well and moderately differentiated HNSCC, the positive staining was predominately located in the cells in the centre of the tumour cell nests (Figure 2 ). Few dysplastic lesions showed positive staining for alpha-B-crystallin. Positive staining was also seen in muscle, salivary glands, blood vessels and in some stromal cells. All, but one of the poorly-differentiated HNSCCs were negative for alpha B-crystallin. Alpha-B-crystallin positive staining was more often seen in the hypopharynx (35%; n= 6/17) and the oral cavity (34%; n=13/41), followed by the larynx (29%; n=8/28) and the oropharynx (19%; n=6/32). There was no correlation found with gender, age, TNM stage and the event of recurrence (Table 2) .
Relationship between p53, alpha-B-crystallin
Twenty-eight per cent (n=33) of the tumours were negative for both p53 and alpha-Bcrystallin and 18% (n=21) were positive for both. There was no correlation noted between p53 and alpha B-crystallin expressions.
Survival analysis
At the time of analysis, 59 patients were alive, 42 had died and 17 patients had no adequate follow-up data. Patients with no adequate follow-up data were excluded from the survival analysis. The median follow-up time for the remaining group was 24.6 months, with a 5-year survival of 30%. The group of patients who were alive at the last date of follow-up Between the different groups of alpha-B-crystallin expression there was no significant difference found in both disease-free and overall survival.
DISCUSSION
The tumour suppressor gene p53 is involved in the regulation of heat shock protein (HSP) in cancer, by repressing the transcription of the heat shock protein genes. If p53 mutation is present in tumour cells, this leads to an increase of transcription of these genes. 14 Recently, it was shown that alpha-B-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. 15 In this study, involving a large cohort of patients, no significant correlation between the expression of p53 and alpha-Bcrystallin was found in HNSCC. It is likely that the correlations between these molecules are more complex.
In this study, the expressions of alpha-B-crystallin were noted to be associated with the tumour cell differentiation. The expression of alpha-B-crystallin was inversely correlated with differentiation; all, except one, of the poorly differentiated tumours were negative for alpha-B-crystallin. The inverse correlation between differentiation and the expression of alpha-B-crystallin has not been described by previous studies on alpha-B-crystallin. Also, the alpha-B-crystallin was noted in the central well-differentiated portion of the HNSCC. This observation has not been described in HNSCC in the literature. This may provide evidence that the well-differentiated HNSCC are more resistance to apoptosis.
In oral squamous cell carcinomas, P53 expression has been related to the grade of differentiation. 16, 17 In this study, p53 expression was also correlated to tumour grade with high percentages of staining more frequently observed in moderately and poorly differentiated carcinomas. In addition, nuclear staining of p53 was noted more frequently in the peripheral portion of the tumour cell nests which is the more poorly-differentiated portion of the tumour. This suggests that alpha-B-crystallin has a potential prognostic value. 11 However, the present study on a large number of patients did not confirm the prognostic role of alpha-B-crystallin with outcome of patients with HNSCC.
There was no correlation found with either disease-free or overall survival. Furthermore, the expression of alpha-B-crystallin was not significantly different in the group of patients with recurrences in comparison to patients who remained disease free.
Previous studies on the relationship between p53 expression and prognosis vary in different populations, reporting either a correlation with overall survival or with relapse or no correlation at all [19] [20] [21] [22] . In this study grade three p53 expression was found to be significant with a shorter overall survival in comparison with lower grade p53 expression.
In conclusion, the expression of both p53 and alpha-B-crystallin is related to the differentiation and the location of the HNSCC. In this study p53 expression has a high prevalence in HNSCC and could therefore be a target for gene therapy. The role of the alpha-B-crystallin in tumourigenesis and its interaction with other proteins is still not clear. There is lack of correlation between alpha-B-crystallin expression and the outcome of patients.
Nevertheless, the presence of alpha-B-crystallin in a proportion of HNSCC implies that it has a role in the pathogenesis of HNSCC. --------------------------------------------------------------------------------------------------- 
